Skip to content

Brain Perfusion Assessment in the Acute Phase of Migraine Aura

Brain Perfusion Assessment in the Acute Phase of Migraine Aura.

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03821584
Acronym
PERCAM
Enrollment
25
Registered
2019-01-30
Start date
2019-03-01
Completion date
2021-07-22
Last updated
2021-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergencies

Keywords

migraine, perfusion arterial, aura brain

Brief summary

The aim of the study is to determine the proportion of patients with change in brain perfusion during the acute phase of migraine attack with aura.

Detailed description

Migraine is a benign and frequent disorder. Migraine aura consists in reversible focal neurological symptoms developing gradually during attack. Its diagnosis relies mainly on patient's history, clinical examination and exclusion of other possible secondary causes to explain transient neurological signs. Thus it can be difficult particularly during first attack or during attack without headache to differentiate migraine aura from transient ischemic stroke. Considering the difference of care management and prognosis, an early distinction of migraine aura based on imaging techniques will have a particular interest. MRI with diffusion, SWI, Flair 2D, ARM 3D TOF, ASL sequences' are routinely performed for the management of acute neurological deficit. Arterial spin labeling (ASL), as a MR perfusion method, will be used to describe brain perfusion during migraine aura. The study hypothesis is that hyperperfusion occurs in brain territories corresponding to the neurological symptoms during migraine aura.

Interventions

OTHERthe difference of care management and prognosis, an early distinction of migraine aura based on imaging techniques will have a particular interest

the difference of care management and prognosis, an early distinction of migraine aura based on imaging techniques will have a particular interest

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age between greater than or equal to 18 * Able to undergo MRI during migraine aura

Exclusion criteria

* Pregnant females * Contraindications towards MRI scanning * History of epilepsy, psychiatric disease, or any other neurologic disease (brain tumors, stroke..). * Presence of abnormalities on the MRI that could explain the neurological deficit. * Adults under guardianship or trusteeship

Design outcomes

Primary

MeasureTime frameDescription
Perfusion pattern of concerned brain areas1 hourPresence or absence of hypo-hyperperfusion using arterial spin labeling. Visual assessments and comparison between hemispheres

Secondary

MeasureTime frameDescription
Pattern of perfusion and aura duration12 monthChange in brain perfusion in relation to neurological deficits (migraine aura) duration.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026